Systematic	O
Identification	B:C0020792
of	O
Pharmacological	O
Targets	O
from	O
Small	O
-	I:C1328819
Molecule	I:C1328819
Phenotypic	O
Screens	I:C0373483
Phenotypic	O
drug	O
discovery	I:C0920472
offers	O
some	O
advantages	O
over	O
target	O
-	O
based	O
methods	O
,	O
mainly	O
because	O
it	O
allows	O
drug	O
leads	I:C0013227
to	O
be	O
tested	O
in	O
systems	O
that	O
more	O
closely	O
model	O
distinct	O
disease	O
states	I:C0231294
.	O

Systematic	O
Identification	O
of	O
Pharmacological	B:C0007992
Targets	O
from	O
Small	O
-	I:C1328819
Molecule	I:C1328819
Phenotypic	O
Screens	I:C0373483
Phenotypic	O
drug	O
discovery	I:C0920472
offers	O
some	O
advantages	O
over	O
target	O
-	O
based	O
methods	O
,	O
mainly	O
because	O
it	O
allows	O
drug	O
leads	I:C0013227
to	O
be	O
tested	O
in	O
systems	O
that	O
more	O
closely	O
model	O
distinct	O
disease	O
states	I:C0231294
.	O

Systematic	O
Identification	O
of	O
Pharmacological	O
Targets	O
from	O
Small	B:C1328819
-	I:C1328819
Molecule	I:C1328819
Phenotypic	O
Screens	I:C0373483
Phenotypic	O
drug	O
discovery	I:C0920472
offers	O
some	O
advantages	O
over	O
target	O
-	O
based	O
methods	O
,	O
mainly	O
because	O
it	O
allows	O
drug	O
leads	I:C0013227
to	O
be	O
tested	O
in	O
systems	O
that	O
more	O
closely	O
model	O
distinct	O
disease	O
states	I:C0231294
.	O

Systematic	O
Identification	O
of	O
Pharmacological	O
Targets	O
from	O
Small	O
-	I:C1328819
Molecule	I:C1328819
Phenotypic	B:C0373483
Screens	I:C0373483
Phenotypic	O
drug	O
discovery	I:C0920472
offers	O
some	O
advantages	O
over	O
target	O
-	O
based	O
methods	O
,	O
mainly	O
because	O
it	O
allows	O
drug	O
leads	I:C0013227
to	O
be	O
tested	O
in	O
systems	O
that	O
more	O
closely	O
model	O
distinct	O
disease	O
states	I:C0231294
.	O

Systematic	O
Identification	O
of	O
Pharmacological	O
Targets	O
from	O
Small	O
-	I:C1328819
Molecule	I:C1328819
Phenotypic	O
Screens	I:C0373483
Phenotypic	O
drug	B:C0920472
discovery	I:C0920472
offers	O
some	O
advantages	O
over	O
target	O
-	O
based	O
methods	O
,	O
mainly	O
because	O
it	O
allows	O
drug	O
leads	I:C0013227
to	O
be	O
tested	O
in	O
systems	O
that	O
more	O
closely	O
model	O
distinct	O
disease	O
states	I:C0231294
.	O

Systematic	O
Identification	O
of	O
Pharmacological	O
Targets	O
from	O
Small	O
-	I:C1328819
Molecule	I:C1328819
Phenotypic	O
Screens	I:C0373483
Phenotypic	O
drug	O
discovery	I:C0920472
offers	O
some	O
advantages	O
over	O
target	O
-	O
based	O
methods	B:C0025663
,	O
mainly	O
because	O
it	O
allows	O
drug	O
leads	I:C0013227
to	O
be	O
tested	O
in	O
systems	O
that	O
more	O
closely	O
model	O
distinct	O
disease	O
states	I:C0231294
.	O

Systematic	O
Identification	O
of	O
Pharmacological	O
Targets	O
from	O
Small	O
-	I:C1328819
Molecule	I:C1328819
Phenotypic	O
Screens	I:C0373483
Phenotypic	O
drug	O
discovery	I:C0920472
offers	O
some	O
advantages	O
over	O
target	O
-	O
based	O
methods	O
,	O
mainly	O
because	O
it	O
allows	O
drug	B:C0013227
leads	I:C0013227
to	O
be	O
tested	O
in	O
systems	O
that	O
more	O
closely	O
model	O
distinct	O
disease	O
states	I:C0231294
.	O

Systematic	O
Identification	O
of	O
Pharmacological	O
Targets	O
from	O
Small	O
-	I:C1328819
Molecule	I:C1328819
Phenotypic	O
Screens	I:C0373483
Phenotypic	O
drug	O
discovery	I:C0920472
offers	O
some	O
advantages	O
over	O
target	O
-	O
based	O
methods	O
,	O
mainly	O
because	O
it	O
allows	O
drug	O
leads	I:C0013227
to	O
be	O
tested	O
in	O
systems	O
that	O
more	O
closely	B:C3810854
model	O
distinct	O
disease	O
states	I:C0231294
.	O

Systematic	O
Identification	O
of	O
Pharmacological	O
Targets	O
from	O
Small	O
-	I:C1328819
Molecule	I:C1328819
Phenotypic	O
Screens	I:C0373483
Phenotypic	O
drug	O
discovery	I:C0920472
offers	O
some	O
advantages	O
over	O
target	O
-	O
based	O
methods	O
,	O
mainly	O
because	O
it	O
allows	O
drug	O
leads	I:C0013227
to	O
be	O
tested	O
in	O
systems	O
that	O
more	O
closely	O
model	O
distinct	O
disease	B:C0231294
states	I:C0231294
.	O

However	O
,	O
a	O
potential	O
disadvantage	O
is	O
the	O
difficulty	O
of	O
linking	O
the	O
observed	O
phenotype	O
to	O
a	O
specific	O
cellular	B:C0007634
target	O
.	O

To	O
address	O
this	O
problem	B:C0033213
,	O
we	O
developed	O
DePick	O
,	O
a	O
computational	O
target	O
de-convolution	O
tool	O
to	O
determine	O
targets	O
specifically	O
linked	O
to	O
small	O
-	I:C1328819
molecule	I:C1328819
phenotypic	O
screens	I:C0373483
.	O

To	O
address	O
this	O
problem	O
,	O
we	O
developed	O
DePick	B:C0037589
,	O
a	O
computational	O
target	O
de-convolution	O
tool	O
to	O
determine	O
targets	O
specifically	O
linked	O
to	O
small	O
-	I:C1328819
molecule	I:C1328819
phenotypic	O
screens	I:C0373483
.	O

To	O
address	O
this	O
problem	O
,	O
we	O
developed	O
DePick	O
,	O
a	O
computational	O
target	O
de-convolution	O
tool	O
to	O
determine	B:C1148554
targets	O
specifically	O
linked	O
to	O
small	O
-	I:C1328819
molecule	I:C1328819
phenotypic	O
screens	I:C0373483
.	O

To	O
address	O
this	O
problem	O
,	O
we	O
developed	O
DePick	O
,	O
a	O
computational	O
target	O
de-convolution	O
tool	O
to	O
determine	O
targets	O
specifically	O
linked	O
to	O
small	B:C1328819
-	I:C1328819
molecule	I:C1328819
phenotypic	O
screens	I:C0373483
.	O

To	O
address	O
this	O
problem	O
,	O
we	O
developed	O
DePick	O
,	O
a	O
computational	O
target	O
de-convolution	O
tool	O
to	O
determine	O
targets	O
specifically	O
linked	O
to	O
small	O
-	I:C1328819
molecule	I:C1328819
phenotypic	B:C0373483
screens	I:C0373483
.	O

We	O
applied	O
DePick	B:C0037589
to	O
eight	O
publicly	O
available	O
screens	O
and	O
predicted	O
59	O
drug	O
target	O
-	O
phenotype	O
associations	O
.	O

We	O
applied	O
DePick	O
to	O
eight	O
publicly	B:C0678367
available	O
screens	O
and	O
predicted	O
59	O
drug	O
target	O
-	O
phenotype	O
associations	O
.	O

We	O
applied	O
DePick	O
to	O
eight	O
publicly	O
available	O
screens	O
and	O
predicted	O
59	O
drug	B:C0013227
target	O
-	O
phenotype	O
associations	O
.	O

In	O
addition	O
to	O
literature	B:C0023866
-	O
based	O
evidence	O
for	O
our	O
predictions	O
,	O
we	O
provide	O
experimental	O
support	O
for	O
seven	O
predicted	O
associations	O
.	O

Interestingly	B:C0543488
,	O
our	O
analysis	O
led	O
to	O
the	O
discovery	O
of	O
a	O
previously	O
unrecognized	O
connection	O
between	O
the	O
Wnt	O
signaling	I:C1520113
pathway	I:C1520113
and	O
an	O
aromatase	O
,	O
CYP19A1	O
.	O

Interestingly	O
,	O
our	O
analysis	B:C0936012
led	O
to	O
the	O
discovery	O
of	O
a	O
previously	O
unrecognized	O
connection	O
between	O
the	O
Wnt	O
signaling	I:C1520113
pathway	I:C1520113
and	O
an	O
aromatase	O
,	O
CYP19A1	O
.	O

Interestingly	O
,	O
our	O
analysis	O
led	O
to	O
the	O
discovery	O
of	O
a	O
previously	O
unrecognized	O
connection	B:C0449379
between	O
the	O
Wnt	O
signaling	I:C1520113
pathway	I:C1520113
and	O
an	O
aromatase	O
,	O
CYP19A1	O
.	O

Interestingly	O
,	O
our	O
analysis	O
led	O
to	O
the	O
discovery	O
of	O
a	O
previously	O
unrecognized	O
connection	O
between	O
the	O
Wnt	B:C1520113
signaling	I:C1520113
pathway	I:C1520113
and	O
an	O
aromatase	O
,	O
CYP19A1	O
.	O

Interestingly	O
,	O
our	O
analysis	O
led	O
to	O
the	O
discovery	O
of	O
a	O
previously	O
unrecognized	O
connection	O
between	O
the	O
Wnt	O
signaling	I:C1520113
pathway	I:C1520113
and	O
an	O
aromatase	B:C0003805
,	O
CYP19A1	O
.	O

Interestingly	O
,	O
our	O
analysis	O
led	O
to	O
the	O
discovery	O
of	O
a	O
previously	O
unrecognized	O
connection	O
between	O
the	O
Wnt	O
signaling	I:C1520113
pathway	I:C1520113
and	O
an	O
aromatase	O
,	O
CYP19A1	B:C3254086
.	O

These	O
results	O
demonstrate	O
that	O
the	O
DePick	B:C0037589
approach	O
can	O
not	O
only	O
accelerate	O
target	O
de-convolution	O
but	O
also	O
aid	O
in	O
discovery	O
of	O
new	O
functionally	O
relevant	O
biological	O
relationships	O
.	O

